同步财经AXSM
Axsome Therapeutics: Sees Current Cash Sufficient to Fund Anticipated Operations Into Cash Flow Positivity
时间：2025-02-18 20:02:11 市场： 美股 综合
Axsome Therapeutics Inc : Mizuho Raises Target Price to $195 From $137
时间：2025-02-11 19:42:53 市场： 美股 综合
Axsome Therapeutics Shares up 17.4% After Settlement Agreement With Teva for Depression Drug
时间：2025-02-10 22:48:52 市场： 综合 美股
Axsome Therapeutics Hosts Symbravo® FDA Approval Virtual Investor Event With Expert Thought Leader
时间：2025-01-31 20:00:00 市场： 美股 综合
Axsome Therapeutics Announces FDA Approval of Symbravo® (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine With or Without Aura in Adults
时间：2025-01-31 04:45:00 市场： 美股 综合
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
时间：2025-01-13 20:00:05 市场： 美股 综合
Axsome Therapeutics Shares Down 15% Premarket After Mixed Data for Experimental Drug to Treat Alzheimer's-Related Agitation
时间：2024-12-30 20:20:01 市场： 美股 综合
Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of Axs-05 in Alzheimer’s Disease Agitation
时间：2024-12-30 20:00:02 市场： 美股 综合
Axsome Therapeutics Inc : Mizuho Raises Target Price to $124 From $106
时间：2024-12-03 18:35:53 市场： 美股 综合
Axsome Therapeutics: on September 30 Entered Into Fifth Amendment to Its Loan & Security Agreement Dated Sept 25, 2020
时间：2024-10-02 05:28:34 市场： 美股 综合